Ocugen Faces Mounting Financial Pressure as Cash Reserves Dwindle
Biotechnology firm Ocugen finds itself navigating turbulent financial waters despite possessing promising gene therapy candidates. The company’s shares have experienced sustained selling pressure, declining in…
